Several previous studies have suggested that, in breast cancer cells overexpressing ErbB2/HER2, it localizes to membrane ruffles or protrusions together with its signaling partners, ErbB1/EGFR and ErbB3/HER3 [10–13, 27, 28, 31, 37, 38]. The gene discussed is EGFR; the disease is breast carcinoma.